Global MRD (Minimal Residual Disease) Testing Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-19581745 | Published Date: 23-Nov-2021 | No. of pages: 110
Table of Content 1 MRD (Minimal Residual Disease) Testing Introduction and Market Overview 1.1 Objectives of the Study 1.2 Overview of MRD (Minimal Residual Disease) Testing 1.3 MRD (Minimal Residual Disease) Testing Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Global MRD (Minimal Residual Disease) Testing Revenue and Growth Rate from 2016-2026 1.4 Market Segmentation 1.4.1 Types of MRD (Minimal Residual Disease) Testing 1.4.2 Applications of MRD (Minimal Residual Disease) Testing 1.4.3 Research Regions 1.5 Market Dynamics 1.5.1 MRD (Minimal Residual Disease) Testing Industry Trends 1.5.2 MRD (Minimal Residual Disease) Testing Drivers 1.5.3 MRD (Minimal Residual Disease) Testing Market Challenges 1.5.4 MRD (Minimal Residual Disease) Testing Market Restraints 1.6 Industry News and Policies by Regions 1.6.1 Industry News 1.6.2 Industry Policies 1.7 Mergers & Acquisitions, Expansion Plans 1.8 MRD (Minimal Residual Disease) Testing Industry Development Trends under COVID-19 Outbreak 1.8.1 Global COVID-19 Status Overview 1.8.2 Influence of COVID-19 Outbreak on MRD (Minimal Residual Disease) Testing Industry Development 2 Industry Chain Analysis 2.1 Upstream Raw Material Supply and Demand Analysis 2.1.1 Global MRD (Minimal Residual Disease) Testing Major Upstream Raw Material and Suppliers 2.1.2 Raw Material Source Analysis 2.2 Major Players of MRD (Minimal Residual Disease) Testing 2.2.1 Major Players Manufacturing Base of MRD (Minimal Residual Disease) Testing in 2020 2.2.2 Major Players Market Distribution in 2020 2.3 MRD (Minimal Residual Disease) Testing Manufacturing Cost Structure Analysis 2.3.1 Production Process Analysis 2.3.2 Manufacturing Cost Structure of MRD (Minimal Residual Disease) Testing 2.3.3 Labor Cost of MRD (Minimal Residual Disease) Testing 2.4 Market Channel Analysis of MRD (Minimal Residual Disease) Testing 2.5 Major Down Stream Customers by Application 3 Global MRD (Minimal Residual Disease) Testing Market, by Type 3.1 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Type (2016-2021) 3.2 Global MRD (Minimal Residual Disease) Testing Production and Market Share by Type (2016-2021) 3.3 Global MRD (Minimal Residual Disease) Testing Revenue and Growth Rate by Type (2016-2021) 3.3.1 Global MRD (Minimal Residual Disease) Testing Revenue and Growth Rate of Flow Cytometry 3.3.2 Global MRD (Minimal Residual Disease) Testing Revenue and Growth Rate of Polymerase Chain Reaction (PCR) 3.3.3 Global MRD (Minimal Residual Disease) Testing Revenue and Growth Rate of Next-Generation Sequencing (NGS) 3.4 Global MRD (Minimal Residual Disease) Testing Price Analysis by Type (2016-2021) 3.4.1 Explanation of Different Type Product Price Trends 4 MRD (Minimal Residual Disease) Testing Market, by Application 4.1 Downstream Market Overview 4.2 Global MRD (Minimal Residual Disease) Testing Consumption and Market Share by Application (2016-2021) 4.3 Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate by Application (2016-2021) 4.3.1 Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Specialty Clinics and Hospitals (2016-2021) 4.3.2 Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Diagnostic Laboratories (2016-2021) 4.3.3 Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Research Institutions (2016-2021) 5 Global MRD (Minimal Residual Disease) Testing Consumption, Revenue ($) by Region (2016-2021) 5.1 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Region (2016-2021) 5.2 Global MRD (Minimal Residual Disease) Testing Consumption and Market Share by Region (2016-2021) 5.3 Global MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.4 North America MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.4.1 North America MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.4.2 North America MRD (Minimal Residual Disease) Testing SWOT Analysis 5.5 Europe MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.5.1 Europe MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.5.2 Europe MRD (Minimal Residual Disease) Testing SWOT Analysis 5.6 China MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.6.1 China MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.6.2 China MRD (Minimal Residual Disease) Testing SWOT Analysis 5.7 Japan MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.7.1 Japan MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.7.2 Japan MRD (Minimal Residual Disease) Testing SWOT Analysis 5.8 Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.8.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.8.2 Middle East and Africa MRD (Minimal Residual Disease) Testing SWOT Analysis 5.9 India MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.9.1 India MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.9.2 India MRD (Minimal Residual Disease) Testing SWOT Analysis 5.10 South America MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.10.1 South America MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.10.2 South America MRD (Minimal Residual Disease) Testing SWOT Analysis 5.11 South Korea MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.11.1 South Korea MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.11.2 South Korea MRD (Minimal Residual Disease) Testing SWOT Analysis 5.12 Southeast Asia MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) 5.12.1 Southeast Asia MRD (Minimal Residual Disease) Testing Market Under COVID-19 5.12.2 Southeast Asia MRD (Minimal Residual Disease) Testing SWOT Analysis 6 Global MRD (Minimal Residual Disease) Testing Production by Top Regions (2016-2021) 6.1 Global MRD (Minimal Residual Disease) Testing Production by Top Regions (2016-2021) 6.2 North America MRD (Minimal Residual Disease) Testing Production and Growth Rate 6.3 Europe MRD (Minimal Residual Disease) Testing Production and Growth Rate 6.4 China MRD (Minimal Residual Disease) Testing Production and Growth Rate 6.5 Japan MRD (Minimal Residual Disease) Testing Production and Growth Rate 6.6 India MRD (Minimal Residual Disease) Testing Production and Growth Rate 7 Global MRD (Minimal Residual Disease) Testing Consumption by Regions (2016-2021) 7.1 Global MRD (Minimal Residual Disease) Testing Consumption by Regions (2016-2021) 7.2 North America MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.3 Europe MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.4 China MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.5 Japan MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.6 Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.7 India MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.8 South America MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.9 South Korea MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 7.10 Southeast Asia MRD (Minimal Residual Disease) Testing Consumption and Growth Rate 8 Competitive Landscape 8.1 Competitive Profile 8.2 Adaptive Biotechnologies Market Performance Analysis 8.2.1 Company Profiles 8.2.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.2.3 Adaptive Biotechnologies Sales, Revenue, Price, Gross Margin 2016-2021 8.2.4 Company Recent Development 8.2.5 Strategies for Company to Deal with the Impact of COVID-19 8.3 Cergentis B.V. Market Performance Analysis 8.3.1 Company Profiles 8.3.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.3.3 Cergentis B.V. Sales, Revenue, Price, Gross Margin 2016-2021 8.3.4 Company Recent Development 8.3.5 Strategies for Company to Deal with the Impact of COVID-19 8.4 ArcherDX, Inc (Invitae) Market Performance Analysis 8.4.1 Company Profiles 8.4.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.4.3 ArcherDX, Inc (Invitae) Sales, Revenue, Price, Gross Margin 2016-2021 8.4.4 Company Recent Development 8.4.5 Strategies for Company to Deal with the Impact of COVID-19 8.5 Invivoscribe Market Performance Analysis 8.5.1 Company Profiles 8.5.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.5.3 Invivoscribe Sales, Revenue, Price, Gross Margin 2016-2021 8.5.4 Company Recent Development 8.5.5 Strategies for Company to Deal with the Impact of COVID-19 8.6 ARUP Laboratories Market Performance Analysis 8.6.1 Company Profiles 8.6.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.6.3 ARUP Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 8.6.4 Company Recent Development 8.6.5 Strategies for Company to Deal with the Impact of COVID-19 8.7 NeoGenomics Laboratories Market Performance Analysis 8.7.1 Company Profiles 8.7.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.7.3 NeoGenomics Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 8.7.4 Company Recent Development 8.7.5 Strategies for Company to Deal with the Impact of COVID-19 8.8 Guardant Health Market Performance Analysis 8.8.1 Company Profiles 8.8.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.8.3 Guardant Health Sales, Revenue, Price, Gross Margin 2016-2021 8.8.4 Company Recent Development 8.8.5 Strategies for Company to Deal with the Impact of COVID-19 8.9 Natera Market Performance Analysis 8.9.1 Company Profiles 8.9.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.9.3 Natera Sales, Revenue, Price, Gross Margin 2016-2021 8.9.4 Company Recent Development 8.9.5 Strategies for Company to Deal with the Impact of COVID-19 8.10 Sysmex Corporation Market Performance Analysis 8.10.1 Company Profiles 8.10.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.10.3 Sysmex Corporation Sales, Revenue, Price, Gross Margin 2016-2021 8.10.4 Company Recent Development 8.10.5 Strategies for Company to Deal with the Impact of COVID-19 8.11 Opko Health Market Performance Analysis 8.11.1 Company Profiles 8.11.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.11.3 Opko Health Sales, Revenue, Price, Gross Margin 2016-2021 8.11.4 Company Recent Development 8.11.5 Strategies for Company to Deal with the Impact of COVID-19 8.12 Mission Bio Market Performance Analysis 8.12.1 Company Profiles 8.12.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.12.3 Mission Bio Sales, Revenue, Price, Gross Margin 2016-2021 8.12.4 Company Recent Development 8.12.5 Strategies for Company to Deal with the Impact of COVID-19 8.13 Asuragen Market Performance Analysis 8.13.1 Company Profiles 8.13.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.13.3 Asuragen Sales, Revenue, Price, Gross Margin 2016-2021 8.13.4 Company Recent Development 8.13.5 Strategies for Company to Deal with the Impact of COVID-19 8.14 Bio-Rad Laboratories Market Performance Analysis 8.14.1 Company Profiles 8.14.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.14.3 Bio-Rad Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 8.14.4 Company Recent Development 8.14.5 Strategies for Company to Deal with the Impact of COVID-19 8.15 LabCorp Market Performance Analysis 8.15.1 Company Profiles 8.15.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.15.3 LabCorp Sales, Revenue, Price, Gross Margin 2016-2021 8.15.4 Company Recent Development 8.15.5 Strategies for Company to Deal with the Impact of COVID-19 8.16 Quest Diagnostics Market Performance Analysis 8.16.1 Company Profiles 8.16.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.16.3 Quest Diagnostics Sales, Revenue, Price, Gross Margin 2016-2021 8.16.4 Company Recent Development 8.16.5 Strategies for Company to Deal with the Impact of COVID-19 8.17 Inivata Market Performance Analysis 8.17.1 Company Profiles 8.17.2 MRD (Minimal Residual Disease) Testing Product Profiles, Application and Specification 8.17.3 Inivata Sales, Revenue, Price, Gross Margin 2016-2021 8.17.4 Company Recent Development 8.17.5 Strategies for Company to Deal with the Impact of COVID-19 9 Global MRD (Minimal Residual Disease) Testing Market Analysis and Forecast by Type and Application 9.1 Global MRD (Minimal Residual Disease) Testing Market Revenue & Volume Forecast, by Type (2021-2026) 9.1.1 Flow Cytometry Market Revenue and Volume Forecast (2021-2026) 9.1.2 Polymerase Chain Reaction (PCR) Market Revenue and Volume Forecast (2021-2026) 9.1.3 Next-Generation Sequencing (NGS) Market Revenue and Volume Forecast (2021-2026) 9.2 Global MRD (Minimal Residual Disease) Testing Market Revenue & Volume Forecast, by Application (2021-2026) 9.2.1 Specialty Clinics and Hospitals Market Revenue and Volume Forecast (2021-2026) 9.2.2 Diagnostic Laboratories Market Revenue and Volume Forecast (2021-2026) 9.2.3 Research Institutions Market Revenue and Volume Forecast (2021-2026) 10 MRD (Minimal Residual Disease) Testing Market Supply and Demand Forecast by Region 10.1 North America Market Supply and Demand Forecast (2021-2026) 10.2 Europe Market Supply and Demand Forecast (2021-2026) 10.3 China Market Supply and Demand Forecast (2021-2026) 10.4 Japan Market Supply and Demand Forecast (2021-2026) 10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026) 10.6 India Market Supply and Demand Forecast (2021-2026) 10.7 South America Market Supply and Demand Forecast (2021-2026) 10.8 South Korea Market Supply and Demand Forecast (2021-2026) 10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026) 10.10 Explanation of Market Size Trends by Region 10.11 MRD (Minimal Residual Disease) Testing Market Trends Analysis 11 New Project Feasibility Analysis 11.1 Industry Barriers and New Entrants SWOT Analysis 11.2 Analysis and Suggestions on New Project Investment 12 Expert Interview Record 13 Research Finding and Conclusion 14 Appendix 14.1 Methodology 14.2 Research Data Source  
List of Tables and Figures Figure Product Picture of MRD (Minimal Residual Disease) Testing Table Product Specification of MRD (Minimal Residual Disease) Testing Figure Market Concentration Ratio and Market Maturity Analysis of MRD (Minimal Residual Disease) Testing Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate from 2016-2026 Table Different Types of MRD (Minimal Residual Disease) Testing Table Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Type (2020-2026) Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) Segment by Type from 2016-2021 Figure Global MRD (Minimal Residual Disease) Testing Market Share by Types in 2020 Figure MRD (Minimal Residual Disease) Testing Flow Cytometry Picture Figure MRD (Minimal Residual Disease) Testing Polymerase Chain Reaction (PCR) Picture Figure MRD (Minimal Residual Disease) Testing Next-Generation Sequencing (NGS) Picture Table Different Applications of MRD (Minimal Residual Disease) Testing Table Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Applications (2020-2026) Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) Segment by Applications from 2016-2021 Figure Global MRD (Minimal Residual Disease) Testing Market Share by Applications in 2020 Figure Specialty Clinics and Hospitals Picture Figure Diagnostic Laboratories Picture Figure Research Institutions Picture Table Research Regions of MRD (Minimal Residual Disease) Testing Table Global MRD (Minimal Residual Disease) Testing Market Size Growth Rate by Region (2020-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Share by Regions in 2020 Figure North America MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure Europe MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure China MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure Japan MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure India MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure South America MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure South Korea MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Figure Southeast Asia MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate (2016-2021) Table SWOT Analysis Table Market Challenges Table Market Restraints Table Industry News Table Industry Policies Table Mergers & Acquisitions, Expansion Plans Table Influence of COVID-19 Outbreak on MRD (Minimal Residual Disease) Testing Industry Development Figure Industry Chain Analysis of MRD (Minimal Residual Disease) Testing Table Major Players Manufacturing Base of MRD (Minimal Residual Disease) Testing in 2020 Table Major Players Market Distribution in 2020 Figure Production Process of MRD (Minimal Residual Disease) Testing Figure Manufacturing Cost Structure of MRD (Minimal Residual Disease) Testing Figure Channel Status of MRD (Minimal Residual Disease) Testing Table Major Distributors of MRD (Minimal Residual Disease) Testing with Contact Information Table Global MRD (Minimal Residual Disease) Testing Revenue ($) by Type (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Production by Type (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Production Share by Type (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Production Share by Type (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate of Flow Cytometry Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate of Polymerase Chain Reaction (PCR) Figure Global MRD (Minimal Residual Disease) Testing Revenue ($) and Growth Rate of Next-Generation Sequencing (NGS) Figure Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2021) Figure Downstream Market Overview Table Global MRD (Minimal Residual Disease) Testing Consumption by Application (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Consumption Market Share by Application (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption Market Share by Application (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Specialty Clinics and Hospitals (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Diagnostic Laboratories (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption and Growth Rate of Research Institutions (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Revenue ($) by Region (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Consumption by Region (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Consumption Market Share by Region (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption Market Share by Region (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table North America MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table North America MRD (Minimal Residual Disease) Testing SWOT Analysis Table Europe MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table Europe MRD (Minimal Residual Disease) Testing SWOT Analysis Table China MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table China MRD (Minimal Residual Disease) Testing SWOT Analysis Table Japan MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table Japan MRD (Minimal Residual Disease) Testing SWOT Analysis Table Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table Middle East and Africa MRD (Minimal Residual Disease) Testing SWOT Analysis Table India MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table India MRD (Minimal Residual Disease) Testing SWOT Analysis Table South America MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table South America MRD (Minimal Residual Disease) Testing SWOT Analysis Table South Korea MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table South Korea MRD (Minimal Residual Disease) Testing SWOT Analysis Table Southeast Asia MRD (Minimal Residual Disease) Testing Consumption, Revenue, Price and Gross Margin (2016-2021) Table Southeast Asia MRD (Minimal Residual Disease) Testing SWOT Analysis Table Global MRD (Minimal Residual Disease) Testing Production by Top Regions (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Production Share by Top Regions (2016-2021) Figure North America MRD (Minimal Residual Disease) Testing Production and Growth Rate Analysis (2016-2021) Figure Europe MRD (Minimal Residual Disease) Testing Production and Growth Rate Analysis (2016-2021) Figure China MRD (Minimal Residual Disease) Testing Production and Growth Rate Analysis (2016-2021) Figure Japan MRD (Minimal Residual Disease) Testing Production and Growth Rate Analysis (2016-2021) Figure India MRD (Minimal Residual Disease) Testing Production and Growth Rate Analysis (2016-2021) Table Global MRD (Minimal Residual Disease) Testing Consumption by Regions (2016-2021) Figure Global MRD (Minimal Residual Disease) Testing Consumption Share by Regions (2016-2021) Figure North America MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure Europe MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure China MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure Japan MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure India MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure South America MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure South Korea MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure Southeast Asia MRD (Minimal Residual Disease) Testing Consumption and Growth Rate Analysis (2016-2021) Figure Top 3 Market Share of MRD (Minimal Residual Disease) Testing Companies in 2020 Figure Top 6 Market Share of MRD (Minimal Residual Disease) Testing Companies in 2020 Table Major Players Revenue ($) Share (2016-2021) Table Company Profiles Table Product Profiles, Application and Specification Table Adaptive Biotechnologies Company Profiles Table Adaptive Biotechnologies Sales, Revenue, Price, Gross Margin 2016-2021 Figure Adaptive Biotechnologies Sales and Growth Rate Figure Adaptive Biotechnologies Revenue ($) Market Share 2016-2021 Table Cergentis B.V. Company Profiles Table Cergentis B.V. Sales, Revenue, Price, Gross Margin 2016-2021 Figure Cergentis B.V. Sales and Growth Rate Figure Cergentis B.V. Revenue ($) Market Share 2016-2021 Table ArcherDX, Inc (Invitae) Company Profiles Table ArcherDX, Inc (Invitae) Sales, Revenue, Price, Gross Margin 2016-2021 Figure ArcherDX, Inc (Invitae) Sales and Growth Rate Figure ArcherDX, Inc (Invitae) Revenue ($) Market Share 2016-2021 Table Invivoscribe Company Profiles Table Invivoscribe Sales, Revenue, Price, Gross Margin 2016-2021 Figure Invivoscribe Sales and Growth Rate Figure Invivoscribe Revenue ($) Market Share 2016-2021 Table ARUP Laboratories Company Profiles Table ARUP Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 Figure ARUP Laboratories Sales and Growth Rate Figure ARUP Laboratories Revenue ($) Market Share 2016-2021 Table NeoGenomics Laboratories Company Profiles Table NeoGenomics Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 Figure NeoGenomics Laboratories Sales and Growth Rate Figure NeoGenomics Laboratories Revenue ($) Market Share 2016-2021 Table Guardant Health Company Profiles Table Guardant Health Sales, Revenue, Price, Gross Margin 2016-2021 Figure Guardant Health Sales and Growth Rate Figure Guardant Health Revenue ($) Market Share 2016-2021 Table Natera Company Profiles Table Natera Sales, Revenue, Price, Gross Margin 2016-2021 Figure Natera Sales and Growth Rate Figure Natera Revenue ($) Market Share 2016-2021 Table Sysmex Corporation Company Profiles Table Sysmex Corporation Sales, Revenue, Price, Gross Margin 2016-2021 Figure Sysmex Corporation Sales and Growth Rate Figure Sysmex Corporation Revenue ($) Market Share 2016-2021 Table Opko Health Company Profiles Table Opko Health Sales, Revenue, Price, Gross Margin 2016-2021 Figure Opko Health Sales and Growth Rate Figure Opko Health Revenue ($) Market Share 2016-2021 Table Mission Bio Company Profiles Table Mission Bio Sales, Revenue, Price, Gross Margin 2016-2021 Figure Mission Bio Sales and Growth Rate Figure Mission Bio Revenue ($) Market Share 2016-2021 Table Asuragen Company Profiles Table Asuragen Sales, Revenue, Price, Gross Margin 2016-2021 Figure Asuragen Sales and Growth Rate Figure Asuragen Revenue ($) Market Share 2016-2021 Table Bio-Rad Laboratories Company Profiles Table Bio-Rad Laboratories Sales, Revenue, Price, Gross Margin 2016-2021 Figure Bio-Rad Laboratories Sales and Growth Rate Figure Bio-Rad Laboratories Revenue ($) Market Share 2016-2021 Table LabCorp Company Profiles Table LabCorp Sales, Revenue, Price, Gross Margin 2016-2021 Figure LabCorp Sales and Growth Rate Figure LabCorp Revenue ($) Market Share 2016-2021 Table Quest Diagnostics Company Profiles Table Quest Diagnostics Sales, Revenue, Price, Gross Margin 2016-2021 Figure Quest Diagnostics Sales and Growth Rate Figure Quest Diagnostics Revenue ($) Market Share 2016-2021 Table Inivata Company Profiles Table Inivata Sales, Revenue, Price, Gross Margin 2016-2021 Figure Inivata Sales and Growth Rate Figure Inivata Revenue ($) Market Share 2016-2021 Table Global MRD (Minimal Residual Disease) Testing Market Revenue ($) Forecast, by Type Table Global MRD (Minimal Residual Disease) Testing Market Volume Forecast, by Type Figure Global MRD (Minimal Residual Disease) Testing Market Revenue ($) and Growth Rate Forecast of Flow Cytometry (2021-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Volume and Growth Rate Forecast of Flow Cytometry (2021-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Revenue ($) and Growth Rate Forecast of Polymerase Chain Reaction (PCR) (2021-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Volume and Growth Rate Forecast of Polymerase Chain Reaction (PCR) (2021-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Revenue ($) and Growth Rate Forecast of Next-Generation Sequencing (NGS) (2021-2026) Figure Global MRD (Minimal Residual Disease) Testing Market Volume and Growth Rate Forecast of Next-Generation Sequencing (NGS) (2021-2026) Table Global Market Revenue ($) Forecast by Application (2021-2026) Table Global Market Volume Forecast by Application (2021-2026) Figure Market Revenue ($) and Growth Rate Forecast of Specialty Clinics and Hospitals (2021-2026) Figure Market Volume and Growth Rate Forecast of Specialty Clinics and Hospitals (2021-2026) Figure Market Revenue ($) and Growth Rate Forecast of Diagnostic Laboratories (2021-2026) Figure Market Volume and Growth Rate Forecast of Diagnostic Laboratories (2021-2026) Figure Market Revenue ($) and Growth Rate Forecast of Research Institutions (2021-2026) Figure Market Volume and Growth Rate Forecast of Research Institutions (2021-2026) Figure North America Market Supply and Growth Rate Forecast (2021-2026) Figure North America Demand and Growth Rate Forecast (2021-2026) Figure Europe Market Supply and Growth Rate Forecast (2021-2026) Figure Europe Demand and Growth Rate Forecast (2021-2026) Figure China Market Supply and Growth Rate Forecast (2021-2026) Figure China Demand and Growth Rate Forecast (2021-2026) Figure Japan Market Supply and Growth Rate Forecast (2021-2026) Figure Japan Demand and Growth Rate Forecast (2021-2026) Figure Middle East and Africa Market Supply and Growth Rate Forecast (2021-2026) Figure Middle East and Africa Demand and Growth Rate Forecast (2021-2026) Figure India Market Supply and Growth Rate Forecast (2021-2026) Figure India Demand and Growth Rate Forecast (2021-2026) Figure South America Market Supply and Growth Rate Forecast (2021-2026) Figure South America Demand and Growth Rate Forecast (2021-2026) Figure South Korea Market Supply and Growth Rate Forecast (2021-2026) Figure South Korea Demand and Growth Rate Forecast (2021-2026) Figure Southeast Asia Market Supply and Growth Rate Forecast (2021-2026) Figure Southeast Asia Demand and Growth Rate Forecast (2021-2026) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery
  • PRICE
  • $3000
    $6000
    $4250

Our Clients